Organigram OGI Reverse Split & OGI Stock Analysis

MindMed Reports Second Quarter 2023 Financial Results and Business Highlights | Psychedelic Invest

Mind Medicine Inc. (NASDAQ: MNMD / NEO: MMED), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today reported its

August 4, 2023

Scientists discover new way to defeat invisible cancer cells

Modern immunotherapies boost the body’s own defenses against cancer. They activate killer T cells of the immune system that can specifically recognize and destroy cancer

June 23, 2023

Owlstone Medical secures $6.5 million to support development of breath-based diagnostics for infectious disease

Funding represents the first time the foundation has taken an equity position in a breath diagnostics company.

April 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.